Eliem Therapeutics, Inc. License Agreements
2 Contracts & Agreements
- Cell Line Development, Manufacturing Services and License Agreement, effective as of February 9, 2021, by and between ValenzaBio, Inc. and ProBioGen, Inc (Filed With SEC on June 27, 2024)
- Amended and Restated License Agreement, dated as of January 11, 2024, by and between Tenet Medicines, Inc. and Cancer Research Technology Limited (Filed With SEC on June 27, 2024)
